Darrin Uecker insider trades: Pulse Biosciences (PLSE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Darrin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | PLSE | ↓ Sell | 45,000 | $16.25 | $731K | Direct | Sep 18, 2025 (1d) |
| Sep 15, 2025 | PLSE | ↓ Sell | 75,000 | $14.96 | $1.1M | Direct | Sep 15, 2025 (0d) |
| Jun 13, 2025 | PLSE | ↓ Sell | 30,000 | $16.19 | $486K | Direct | Jun 16, 2025 (3d) |
| Jun 10, 2005 | RITA | ↑ Buy | 3,500 | $2.85 | $10K | Direct | Jun 10, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PLSE insiders
Open-market trades in the last 12 months
About Darrin Uecker's insider trades
Darrin Uecker is Chief Technology Officer at Pulse Biosciences (PLSE). Since Jun 10, 2005, Darrin has reported 1 open-market purchase worth $10K and 3 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), option exercises (6 filings), other transactions (2 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLSE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.